Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

被引:0
|
作者
Rosanna Di Paola
Salvatore Cuzzocrea
机构
[1] University of Messina,Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine
[2] Torre Biologica-Policlinico Universitario,undefined
[3] IRCCS Centro Neurolesi Bonino-Pulejo,undefined
关键词
Peroxisome proliferator-activated receptors; Ischemia; Reperfusion tissue injury;
D O I
暂无
中图分类号
学科分类号
摘要
Peroxisome proliferator-activated receptors (PPARs) belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes like regulation of glucose and lipid redistribution. They also have anti-atherogenic, anti-inflammatory as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with ischemia and reperfusion. The potential utility of PPAR ligands in ischemia and reperfusion will be discussed in this review.
引用
收藏
页码:157 / 175
页数:18
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats
    Collino, Massimo
    Benetti, Elisa
    Miglio, Gianluca
    Castiglia, Sara
    Rosa, Arianna Carolina
    Aragno, Manuela
    Thiemermann, Christoph
    Fantozzi, Roberto
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (02) : 345 - 353
  • [42] Peroxisome Proliferator-Activated Receptor-α Contributes to the Resolution of Inflammation after Renal Ischemia/Reperfusion Injury
    Patel, Nimesh S. A.
    di Paola, Rosanna
    Mazzon, Emanuela
    Britti, Domenico
    Thiemermann, Christoph
    Cuzzocrea, Salvatore
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (02): : 635 - 643
  • [43] Peroxisome proliferator-activated receptor ligands in atherosclerosis
    Viles-Gonzalez, JF
    Choi, BG
    Fuster, V
    Badimon, JJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1393 - 1403
  • [44] Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (08) : 943 - 959
  • [45] Peroxisome proliferator-activated receptors and renal diseases
    Wu, Jing
    Chen, Lihong
    Zhang, Dongjuan
    Huo, Ming
    Zhang, Xiaoyan
    Pu, Dan
    Guan, Youfei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 995 - 1009
  • [46] Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis
    Vanden Heuvel, JP
    TOXICOLOGICAL SCIENCES, 1999, 47 (01) : 1 - 8
  • [47] Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
    Sheng, Weibei
    Wang, Qichang
    Qin, Haotian
    Cao, Siyang
    Wei, Yihao
    Weng, Jian
    Yu, Fei
    Zeng, Hui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [48] Peroxisome proliferator-activated receptors: good and bad
    Staels, B.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2008, 154 : S15 - S16
  • [49] Peroxisome proliferator-activated receptors and shock state
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    Meli, Rosaria
    THESCIENTIFICWORLDJOURNAL, 2006, 6 : 1770 - 1782
  • [50] Role of peroxisome proliferator-activated receptors in osteoarthritis
    Huang, Gang
    Jiang, Wei
    Xie, Weiyong
    Lu, Wei
    Zhu, Weimin
    Deng, Zhenhan
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)